Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacks (Q44515041)

3 December 2017

title

Pulmonary and systemic nitric oxide measurements during CCK-5-induced panic attacks (English)

1 reference

3 December 2017

Nathalie Lara

1

1 reference

3 December 2017

Wendy E Chrapko

2

1 reference

3 December 2017

Stephen L Archer

3

1 reference

3 December 2017

François Bellavance

4

1 reference

3 December 2017

Irvin Mayers

5

1 reference

3 December 2017

Jean-Michel Le Mellédo

6

1 reference

3 December 2017

language of work or name

English

0 references

publication date

1 October 2003

1 reference

3 December 2017

published in

Neuropsychopharmacology

1 reference

3 December 2017

volume

28

1 reference

3 December 2017

issue

10

1 reference

3 December 2017

page(s)

1840-1845

1 reference

Persistent respiratory irregularity in patients with panic disorder.

3 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Panic disorder and cigarette smoking behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Nitric oxide deficiency in fenfluramine- and dexfenfluramine-induced pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Nitric oxide and lung disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Excess mortality in panic disorder. A comparison with primary unipolar depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Mortality among outpatients with anxiety disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Origins of Breath Nitric Oxide in Humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Endogenous nitric oxide is present in the exhaled air of rabbits, guinea pigs and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

CSF cholecystokinin concentrations in patients with panic disorder and in normal comparison subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Effect of dietary control on plasma nitrate level and estimation of basal systemic nitric oxide production rate in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

The effect of cholecystokinin tetrapeptide on respiratory resistance in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Assessment of nitric oxide formation during exercise.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Cholecystokinin in anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Panic disorder and cardiovascular/cerebrovascular problems: results from a community survey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

Measurement of nitric oxide in biological models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Is NO an endogenous antiatherogenic molecule?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Panic disorder and mortality.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Panic attacks during placebo procedures in the laboratory. Physiology and symptomatology

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Prospective study of phobic anxiety and risk of coronary heart disease in men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

The role of the beta-noradrenergic system in cholecystokinin-tetrapeptide-induced panic symptoms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Nitric oxide is present in exhaled breath in humans: direct GC-MS confirmation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Panic disorder: coronary spasm as a basis for cardiac risk?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Exhaled nitric oxide during exercise: site of release and modulation by ventilation and blood flow

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Exhaled nitric oxide during exercise in primary pulmonary hypertension and pulmonary fibrosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Nitric oxide measured with single-breath and tidal-breathing methods in asthma and COPD

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

The prevalence of respiratory disorders in panic disorder, major depressive disorder and V-code patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Effects of diet on measurement of nitric oxide metabolites

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Nitric oxide and the lung

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300241

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300241

1 reference

3 December 2017

1 reference